Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Frankrijk
  4. Euronext Paris
  5. Cellectis S.A.
  6. Nieuws
  7. Andere talen
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Rapport
Real Time Euronext Paris  -  17:35 06-10-2022
2.448 EUR   +5.06%
05/10Europese ADR's bewegen sterk lager in de woensdaghandel
MT
29/09Europese ADR's bewegen lager in de donderdaghandel
MT
29/09Biofarmaceutisch concern Cellectis neemt Chief Medical Officer aan
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op CELLECTIS S.A.
11:12Cellectis : présentera des données contre le cancer
09:21Bolsa de Madrid: El mercado recupera parte de su libido
09:03Le marché retrouve un peu de sa libido
08:44EN DIRECT DES MARCHES : Engie, STMicro, EDF, Nexans, Aramis, GE, T..
05/10Cellectis présentera des données précliniques sur des cellules “smart” CAR ..
05/10Cellectis to Present Pre-Clinical Data on TALENģ-edited Smart CAR T-cells Supporting Im..
05/10Cellectis to Present Pre-Clinical Data on TALENģ-edited Smart CAR T-cells Supporting Im..
05/10European ADRs Move Sharply Lower in Wednesday Trading
03/10Calyxt, Inc. : Entry into a Material Definitive Agreement, Other Events, Financial Stateme..
29/09European ADRs Move Lower in Thursday Trading
29/09Ça s'emballe derrière la Banque d'Angleterre
29/09EN DIRECT DES MARCHES : Sanofi, Renault, Accor, Worldline, Valneva..
29/09Biopharmaceutical Group Cellectis Hires Chief Medical Officer
28/09Cellectis Promotes Mark Frattini to Chief Medical Officer
28/09Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
28/09Cellectis Appoints Mark Frattini as Chief Medical Officer
28/09Cellectis nomme Mark Frattini, M.D., Ph.D., en tant que directeur médical
27/09Cellectis S A : Document AMF CP. 2022E863159
23/09European ADRs Fall in Friday Trading
23/09Allogene Stocks Fall as Servier Abandons Anti-CD19 Partnership
22/09Cellectis S.A. and Les Laboratoires Servier Sas and Institut De Recherches Internationa..
22/09Calyxt, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
21/09European ADRs Move Lower in Wednesday Trading
20/09European ADRs Move Lower in Tuesday Trading
19/09Zentalis Pharmaceuticals Hires Carrie Brownstein as Chief Medical Officer
08/09European ADRs Move Slightly Higher in Thursday Trading
07/09European ADRs Move Lower in Wednesday Trading
07/09Transcript : Cellectis S.A. Presents at Citi's 17th Annual BioPharma Conferen..
06/09European ADRs Move Higher in Tuesday Trading
05/09Cellectis S A : Corporate Presentation - September 2022
02/09European ADRs Climb Sharply Higher in Friday Trading
01/09Cellectis annonce sa participation à quatre conférences investisseurs en septembre
01/09Cellectis annonce sa participation à quatre conférences investisseurs en septembre
01/09Cellectis Announces Participation in Four Upcoming Investor Conferences in September
01/09Cellectis S A : Document AMF CP. 2022E858948
31/08European ADRs Fall in Wednesday Trading
26/08European ADRs Move Lower in Friday Trading
25/08Cellectis S A : Document AMF CP. 2022E858188
24/08European ADRs Move Lower in Wednesday Trading
22/08European ADRs Move Lower in Monday Trading
19/08European ADRs Move Lower in Friday Trading
18/08European ADRs Move Lower in Thursday Trading
17/08European ADRs Move Lower in Wednesday Trading
16/08Cellectis S A : Document AMF CP. 2022E857305
15/08European ADRs Move Sharply Lower in Monday Trading
12/08European ADRs Move Slightly Lower in Friday Trading
11/08European ADRs Move Lower in Thursday Trading
10/08Cellectis S A : Document AMF CP. 2022E856958
09/08European ADRs Move Higher in Tuesday Trading
08/08European ADRs Move Higher in Monday Trading
05/08European ADRs Move Lower in Friday Trading
05/08Transcript : Cellectis S.A., Q2 2022 Earnings Call, Aug 05, 2022
05/08Cellectis : activités financées jusqu'à début 2024
04/08Cellectis S A : PRELIMINARY NOTE - Form 6-K
04/08Calyxt : Q2 Earnings Snapshot
04/08Cellectis S A : Provides Business Update and Reports Financial Results for Second Quarter ..
04/08Cellectis S A : Provides Business Update and Reports Financial Results for Second Quarter ..
04/08CALYXT, INC. Management's Discussion and Analysis of Financial Condition and Results o..
04/08Cellectis S.A. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
04/08Cellectis publie ses résultats financiers du deuxième trimestre 2022
04/08Cellectis S.A. Announces Executive Changes
04/08Cellectis Provides Business Update and Reports Financial Results†for Second Quarter 202..
04/08European ADRs Move Higher in Thursday Trading
03/08European ADRs Nudge Higher in Wednesday Trading
02/08Cellectis Receives FDA Clearance to Launch Phase 1/2a Lymphoma Trial
02/08Cellectis : le titre grimpe après un feu vert de la FDA
02/08Cellectis Gets US FDA Nod To Start Trial For Non-Hodgkin Lymphoma Treatment
01/08Cellectis S A : Receives IND clearance for UCART20x22, its First in-house Manufactured Pro..
01/08Cellectis reçoit l'accord de la FDA pour démarrer un essai clinique sur UCART20x22, son..
01/08Cellectis Receives IND clearance for UCART20x22, its First in-house Manufactured Produc..
01/08Cellectis reçoit l'accord de la FDA pour démarrer un essai clinique sur UCART20x22, son..
01/08Cellectis Receives IND clearance for UCART20x22, its First in-house Manufactured Produc..
01/08Cellectis S.A. Announces U.S. Food and Drug Administration Clear Cellectis’ Invest..
01/08European ADRs Move Higher in Monday Trading
28/07Cellectis S A : to Report Second Quarter 2022 Financial Results - Form 6-K
28/07Cellectis to Report Second Quarter 2022 Financial Results
28/07Cellectis organise une conférence téléphonique pour présenter ses résultats financiers ..
28/07Cellectis organise une conférence téléphonique pour présenter ses résultats financiers ..
28/07Cellectis to Report Second Quarter 2022 Financial Results
28/07European ADRs Decline in Thursday Trading
27/07European ADRs Move Higher in Wednesday Trading
20/07European ADRs Move Lower in Wednesday Trading
15/07European ADRs Move Higher in Friday Trading
14/07European ADRs Tumble Lower in Thursday Trading
12/07European ADRs Move Lower in Tuesday Trading
11/07European ADRs Move Lower in Monday Trading
07/07European ADRs Move Higher in Thursday Trading
05/07Pharnext : recrute le directeur juridique de OSE Immuno
30/06Cellectis dévoile dans Nature Communications de nouvelles cellules CAR T universelles i..
30/06Cellectis dévoile dans Nature Communications de nouvelles cellules CAR T universelles i..
30/06Cellectis Publishes Article in Nature Communications Unveiling Novel Immune-Evasive Uni..
30/06Cellectis Publishes Article in Nature Communications Unveiling Novel Immune-Evasive Uni..
30/06Cellectis Publishes Article in Nature Communications Unveiling Novel Immune-Evasive Uni..
29/06European ADRs Move Slightly Higher in Wednesday Trading
29/06Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D..
29/06Cellectis S.A. Reports Results from Annual Shareholders' General Meeting Held on June 2..
29/06Le consommateur américain sous surveillance
29/06EN DIRECT DES MARCHES : EssilorLuxottica, Eurazeo, Ipsen, GTT, Nov..
28/06Cellectis S A : VOTE RESULTS- Cellectis- Annual Shareholders Meeting - June, 28, 2022
28/06Cellectis S A : Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, ..
Volgende evenement op CELLECTIS S.A.